FDA approves Pfizer’s COVID booster for children 12 to 15
The Centers for Disease Control and Prevention meets Wednesday to discuss giving final approval.
Pfizer
FDA approves first antiviral pill for treatment of COVID
Pfizer's Paxlovid pill is designed for the treatment of mild-to-moderate cases of COVID-19 in patients 12 and older.
Opinion
Opinion
Follow this topic to stay updated on recent posts.
See recent postsScience is winning
And then it hit me. Most people aren’t afraid of the vaccine. They want it, for themselves and their children.
FDA authorizes Pfizer’s COVID vaccine for use with kids 5 to 11
A CDC advisory committee is to debate the vaccine for those younger children on Tuesday. The CDC director will have final say.
UAB pediatrician urges parents to vaccinate children 5 to 11 once available
COVID-19 is the eighth leading cause of death for the age group.
Report: Mo Brooks failed to disclose personal stock sales
Brooks sold up to $50,000 in a vaccine-maker's stock and didn't report the sale for nearly two months.
FDA fully approves Pfizer’s COVID-19 vaccine
Many in the medical community have been awaiting this action, hopeful it will result in more people becoming vaccinated.
WTO to meet to consider temporarily lifting vaccine patent protection
According to the UN, wealthy countries received 82 percent of vaccine doses, while poor nations received less than 1 percent.
How is the COVID vaccine safe if they made it so fast? A UAB doctor explains
Four key things, some of which were in motion for decades, came together at the right time.
Alabama opens Pfizer’s COVID-19 vaccine to ages 12 to 15
Public health officials urge parents to get their children 12 and up vaccinated to ease a return to school next year and prevent outbreaks.